EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte Studie

The effects of cannabidiol on sleep disturbances within a sample of high trait worriers: A double-blind, randomized placebo controlled trial.

L Riley Gournay, Morgan L Ferretti iD, Harrison B Dickens, Veronica Floyd, Daniella A Fernandez, Ezri Rathbun, Anna-Marie Nguyen, Ellen W Leen-Feldner

Experimental and Clinical Psychopharmacology · 2026

DOI: 10.1037/pha0000832 ↗

At a glance

Randomisierte kontrollierte Studie in Experimental and Clinical Psychopharmacology, 2026. Written by L Riley Gournay and 7 co-authors. Institution: Department of Psychological Sciences, University of Arkansas. Major MEDLINE topics: Anxiety, Cannabidiol, Sleep Aids, Pharmaceutical, Sleep Wake Disorders.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cannabidiol (CBD), a nonintoxicating molecule derived from the cannabis plant, is garnering attention as a novel sleep aid despite a dearth of empirical literature supporting its efficacy for sleep-related indications. The present study aimed to address this gap. Participants were 63 individuals (Mage = 29.27; SDage = 9.58) reporting elevated trait worry who were randomly assigned to take 300 mg CBD, 50 mg CBD, or placebo daily for 2 weeks. Results suggested 300 mg CBD decreased sleep disturbances and sleep quality significantly more than 50 mg CBD (B = -0.39, t = -2.59, p < .05, d = 0.08), but not placebo (B = -0.32, t = -2.09, p = .10, d = 0.07) with no effects on sedation or cognitive impairment. These data suggest 300 mg CBD showed significantly greater improvement than 50 mg CBD but did not show statistically significant improvement compared to placebo. More work is needed to assert strong conclusions regarding CBD's effects on sleep-related indicators. (PsycInfo Database Record (c) 2026 APA, all rights reserved).

Subjects

MeSH terms (MEDLINE)

AnxietyCannabidiolSleep Aids, PharmaceuticalSleep Wake DisordersAdultFemaleHumansMaleYoung AdultDose-Response Relationship, DrugDouble-Blind MethodSleep Quality

Substances

CannabidiolSleep Aids, Pharmaceutical

Authors and institutions

  • Department of Psychological Sciences, University of Arkansas.

ORCID profiles: Morgan L Ferretti

Cite

APA

Gournay, L. R., Ferretti, M. L., Dickens, H. B., Floyd, V., Fernandez, D. A., Rathbun, E., Nguyen, A. M., & Leen-Feldner, E. W. (2026). The effects of cannabidiol on sleep disturbances within a sample of high trait worriers: A double-blind, randomized placebo controlled trial. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000832

Vancouver

Gournay LR, Ferretti ML, Dickens HB, Floyd V, Fernandez DA, Rathbun E, et al. The effects of cannabidiol on sleep disturbances within a sample of high trait worriers: A double-blind, randomized placebo controlled trial. Experimental and Clinical Psychopharmacology. 2026. doi:10.1037/pha0000832

BibTeX
@article{Gournay2026,
  author = {Gournay, L Riley and Ferretti, Morgan L and Dickens, Harrison B and Floyd, Veronica and Fernandez, Daniella A and Rathbun, Ezri and Nguyen, Anna-Marie and Leen-Feldner, Ellen W},
  title = {The effects of cannabidiol on sleep disturbances within a sample of high trait worriers: A double-blind, randomized placebo controlled trial},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2026},
  doi = {10.1037/pha0000832}
}
Start for free →